$0.048
(0%)
|
High - |
Low - |
Trades - |
Turnover $0 |
Volume 0 |
| 11 November 2026 at 10:34pm | ||||
SUDA PHARMACEUTICALS LTD
Pharmaceuticals, Biotechnology & Life Sciences
|
Market Cap (11-Nov) $23,079,360 (1,609th) |
Close (25-Oct) $0.048 |
Volume (25-Oct) 0 |
Shortsold (25-Jun) 3,768 (0.00%) (647th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.019 |
SUDA signs Licence and Distribution Agreement with STADA
SUD released this announcement to the ASX on 24 August 2021, 10:43. The announcement is marked as price sensitive, and is 3 page(s) in length and 202.74kb in size.
You can view all announcements from SUD and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from SUD | |
|---|---|
| SUDA becomes Arovella Therapeutics | 22 October 2021, 8:20 |
| Chile Ministry of Health Approval Granted for ZolpiMist | 21 October 2021, 10:00 |
| Results of General Meeting | 14 October 2021, 13:51 |
| SUDA signs Licence and Distribution Agreement with STADA | 24 August 2021, 10:43 |
| ZolpiMist Update | 23 August 2021, 15:33 |
| iNKT cell therapy platform update | 16 August 2021, 9:54 |
| Initial Director's Interest Notice | 12 August 2021, 9:47 |
If you were already registered, log in here.
If you were already registered, log in here.